US PTAB IP Litigation
8,722 annotated decisions
Page 42 of 364 · 8,722 total
patent · Sep 5, 2025
Carbyne, Inc. et al. v.Tritech Software Systems et al.
· IPR2025-00959
Carbyne petitions the PTAB to invalidate Tritech’s RE50016 reissued patent covering emergency call text messaging. The petition alleges obviousness over four prior‑art references—Brooks, SARLOC, Salafia, and Marr—asserting that the claimed system was well‑known. It seeks institution of the IPR and cancellation of the challenged claims.
patent · Sep 5, 2025
Apple Inc. v.Advanced Coding Technologies LLC
· IPR2025-00984
Apple has filed an IPR petition challenging claims 2‑4 and 11 of U.S. Patent 10,218,995, asserting obviousness over a combination of prior‑art video‑coding references. The petition seeks institution of the review and cancellation of the challenged claims.
patent · Sep 5, 2025
Apple Inc. v.Advanced Coding Technologies LLC
· IPR2025-00983
Apple has filed an IPR petition challenging claims 1‑2 of the ’303 video‑coding patent, asserting obviousness over Demircin and Kimoto references. The petition seeks institution and cancellation of the claims.
patent · Sep 5, 2025
Mercedes-Benz Group AG, Mercedes-Benz AG et al. v.Phelan Group, LLC
· IPR2025-00986
Mercedes‑Benz seeks cancellation of all 18 claims of U.S. Patent 9,493,149, arguing they are obvious over multiple prior‑art references and that discretionary factors favor institution.
patent · Sep 5, 2025
Google LLC v.Sandpiper CDN, LLC
· IPR2025-00969
Google has filed an IPR petition seeking to invalidate 26 claims of Sandpiper CDN’s CDN caching patent. The petition relies on obviousness over Kenner and on combinations with Vetter, Rekimoto, and Boyles, and also challenges claim 28 under §112. The Board has yet to decide whether to institute review.
patent · Sep 5, 2025
Google LLC v.Cellular South Inc
· IPR2025-00876
Google has filed an IPR petition seeking to invalidate Cellular South’s 10,218,954 patent covering video‑to‑data methods, asserting obviousness over Kritt, Fontana, and Lau references and noting no discretionary denial issues.
patent instituted · Sep 5, 2025
Imperative Care, Inc. v.Inari Medical, Inc. et al.
· IPR2025-00989
Imperative Care successfully challenged the patentability of Inari Medical's hemostasis valve claims before the PTAB, leading to institution on grounds of anticipation and obviousness. The Board focused heavily on claim construction, ultimately defining 'filament' as a flexible length of material necessary for the device function. This decision sets important precedent regarding functional limitations in medical device patents.
patent denied · Sep 5, 2025
American Airlines, Inc. et al. v.Intellectual Ventures I LLC
· IPR2025-00987
The PTAB denied the IPR petition filed by American Airlines and Southwest Airlines against Intellectual Ventures I LLC, finding that the petitioner failed to establish a reasonable likelihood of prevailing. The Board specifically rejected arguments regarding obviousness over combinations of prior art references like Lawson, Tsutsumitake, and Choquier in the dynamic routing network space.
patent instituted · Sep 5, 2025
Google LLC v.Sandpiper CDN, LLC
· IPR2025-00969
Google LLC successfully convinced the PTAB to institute IPR against Sandpiper CDN's patent 8478903, asserting that the core technology was obvious over prior art like Kenner.
patent denied · Sep 5, 2025
Carbyne, Inc. et al. v.Tritech Software Systems et al.
· IPR2025-00959
The Director denied the institution of IPR2025-00959, vacating a prior decision because Carbyne failed to explain inconsistencies in its claim construction arguments between district court and PTAB.
patent instituted · Sep 5, 2025
Carbyne, Inc. et al. v.Tritech Software Systems et al.
· IPR2025-00959
Carbyne successfully instituted IPR proceedings against Tritech Software Systems regarding emergency SMS/geolocation technology. The Board found a reasonable likelihood of prevailing on multiple grounds of obviousness (103) over various combinations of prior art references, including Brooks and SARLOC.
patent · Sep 1, 2025
Dabico Airport Solutions Inc. et al. v.AXA POWER APS et al.
· IPR2025-00408
AXA Power defends the USPTO Director's discretionary denial of Dabico's IPR petition, arguing the Director acted within broad authority under 35 U.S.C. § 314(a) and applied a holistic assessment. The Patent Owner contends the petitioner misapplies the review standard and seeks denial of the request for Director Review.
patent denied · Sep 1, 2025
Dabico Airport Solutions Inc. et al. v.AXA POWER APS et al.
· IPR2025-00408
The PTAB denied Dabico Airport’s request for Director Review of a denied institution decision, leaving AXA Power’s patent in force.
patent · Sep 1, 2025
Dabico Airport Solutions Inc. et al. v.AXA POWER APS et al.
· IPR2025-00408
Dabico Airport Solutions has petitioned the PTAB Director to overturn a denial of institution for its IPR against AXA POWER APS’s ‘169 patent. The petitioner argues the Director improperly applied a new “settled expectations” discretionary denial standard without notice. The request seeks vacatur of the decision or additional briefing.
patent · Sep 1, 2025
Azurity Pharmaceuticals, Inc. v.EXELIXIS, INC.
· IPR2025-00427
Azurity has filed an IPR petition seeking cancellation of all 22 claims of Exelixis’s U.S. 12,128,039 patent, arguing obviousness over Brown combined with Kubo and Robinson references.
patent · Sep 1, 2025
Dabico Airport Solutions Inc. et al. v.AXA POWER APS et al.
· IPR2025-00408
Dabico Airport Solutions has filed an IPR petition challenging all 22 claims of AXA Power’s preconditioned‑air‑unit patent, asserting that the claimed features are obvious over multiple HVAC prior‑arts. The petition cites Kreymer, Taras, Takahashi, Carrier and Lechmotoren as teaching the same elements.
patent · Sep 1, 2025
Cisco Systems, Inc. v.WSOU Investments LLC d/b/a Brazos Licensing and Development
· IPR2025-00429
Cisco has filed an IPR petition challenging claims 1 and 17 of WSOU’s U.S. 9,450,884 patent, asserting obviousness over multiple prior‑art references. The petition also argues that discretionary denial is inappropriate and requests institution of the review.
patent terminated or settled · Aug 31, 2025
BOE Technology Group Co., Ltd. v.Samsung Display Co., Ltd.
· IPR2025-01499
BOE Technology and Samsung Display settled their IPR disputes, leading the PTAB to terminate the proceedings without a trial. The settlement agreement is confidential per 37 C.F.R. § 42.74(c).
patent · Aug 31, 2025
BOE Technology Group Co., Ltd. v.Samsung Display Co., Ltd.
· IPR2025-01499
BOE and Samsung filed a joint request to keep their IPR settlement agreement confidential, invoking statutory confidentiality provisions. The request seeks to separate the settlement from the patent file and limit its disclosure.
patent · Aug 31, 2025
BOE Technology Group Co., Ltd. v.Samsung Display Co., Ltd.
· IPR2025-01498
BOE and Samsung filed a joint request asking the PTAB to keep their settlement agreement confidential under 35 U.S.C. § 317(b). The request seeks to separate the agreement from the patent file and limit its disclosure.
patent terminated or settled · Aug 31, 2025
BOE Technology Group Co., Ltd. et al. v.Samsung Display Co., Ltd.
· IPR2025-01479
BOE Technology and Samsung Display settled their IPR dispute over patent 11,574,991 B2 before trial, leading the PTAB to terminate the proceeding.
patent terminated or settled · Aug 31, 2025
BOE Technology Group Co., Ltd. et al. v.Samsung Display Co., Ltd.
· IPR2025-01477
BOE Technology and Samsung Display settled IPR2025-01477 before trial. The Board granted a joint motion to terminate, keeping the settlement confidential. No claim validity was decided.
patent terminated or settled · Aug 31, 2025
BOE Technology Group Co., Ltd. et al. v.Samsung Display Co., Ltd.
· IPR2025-01476
BOE Technology and Samsung Display jointly settled eight IPR challenges to Patent 10,541,279, leading the PTAB to terminate the proceedings before trial.
patent terminated or settled · Aug 31, 2025
BOE Technology Group Co., Ltd. v.Samsung Display Co., Ltd.
· IPR2025-01498
BOE Technology and Samsung Display have settled all disputes in IPR2025-01498 concerning U.S. Patent 10,720,483 and jointly moved to terminate the proceeding under 35 U.S.C. §317.